Global Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Disease Pathology, Therapeutic Applications, Application, End-use - Forecast 2024-2030- Product Image

Sale

Global Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Disease Pathology, Therapeutic Applications, Application, End-use - Forecast 2024-2030

Report
180 Pages
March 2024
Region: Global
360iResearch™
ID: 5674201

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Neurovascular Intervention Devices Market size was estimated at USD 3.75 billion in 2023, USD 3.95 billion in 2024, and is expected to grow at a CAGR of 6.47% to reach USD 5.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neurovascular Intervention Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Boston Scientific Corporation, Evasc Medical Systems Corp., Johnson & Johnson Services, Inc., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Microport Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Balloon Systems
- Carotid Stents
- Catheters
- Embolic Coils
- Embolic Protection Devices
- Flow Diverters
- Guidewires
- Intracranial Stents
- Intrasaccular Devices
- Neurothrombectomy Devices
- Stent Retrievers
Process
- Carotid Endarterectomy
- Cerebral Angiography
- Coiling
- Flow Diversion
- Microsurgical Clipping
- Neurothrombectomy
- Stenting
Disease Pathology
- Arteriovenous Malformations & Fistulas
- Carotid Artery Stenosis
- Cerebral Aneuryms
- Ischemic Strokes
Therapeutic Applications
- Brain Aneurysm
- Ischemic Strokes
- Stenosis
Application
- Arteriovenous Malformation
- Intracranial Aneurysm
- Ischemic Stroke
End-use
- Ambulatory Surgical Centers
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Neurovascular Intervention Devices Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurovascular Intervention Devices Market?
What are the technology trends and regulatory frameworks in the Neurovascular Intervention Devices Market?
What is the market share of the leading vendors in the Neurovascular Intervention Devices Market?
Which modes and strategic moves are suitable for entering the Neurovascular Intervention Devices Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Neurovascular Intervention Devices Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for effective neurovascular devices
5.1.1.2. Government initiatives to modernize and expand healthcare infrastructure across emerging markets
5.1.1.3. Improvements in medical reimbursement in mature economies
5.1.2. Restraints
5.1.2.1. Stringent regulatory scenario associated with neurovascular intervention devices
5.1.3. Opportunities
5.1.3.1. Rising number of researches in the field of neurovascular therapies
5.1.3.2. Growing awareness among neurosurgeons about minimally invasive surgical procedures
5.1.4. Challenges
5.1.4.1. Lack of skilled neurosurgeons
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Neurovascular Intervention Devices Market, by Product

6.1. Introduction
6.2. Balloon Systems
6.3. Carotid Stents
6.4. Catheters
6.5. Embolic Coils
6.6. Embolic Protection Devices
6.7. Flow Diverters
6.8. Guidewires
6.9. Intracranial Stents
6.10. Intrasaccular Devices
6.11. Neurothrombectomy Devices
6.12. Stent Retrievers

7. Neurovascular Intervention Devices Market, by Process

7.1. Introduction
7.2. Carotid Endarterectomy
7.3. Cerebral Angiography
7.4. Coiling
7.5. Flow Diversion
7.6. Microsurgical Clipping
7.7. Neurothrombectomy
7.8. Stenting

8. Neurovascular Intervention Devices Market, by Disease Pathology

8.1. Introduction
8.2. Arteriovenous Malformations & Fistulas
8.3. Carotid Artery Stenosis
8.4. Cerebral Aneuryms
8.5. Ischemic Strokes

9. Neurovascular Intervention Devices Market, by Therapeutic Applications

9.1. Introduction
9.2. Brain Aneurysm
9.3. Ischemic Strokes
9.4. Stenosis

10. Neurovascular Intervention Devices Market, by Application

10.1. Introduction
10.2. Arteriovenous Malformation
10.3. Intracranial Aneurysm
10.4. Ischemic Stroke

11. Neurovascular Intervention Devices Market, by End-use

11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals

12. Americas Neurovascular Intervention Devices Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Neurovascular Intervention Devices Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Neurovascular Intervention Devices Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player

16. Competitive Portfolio

16.1. Key Company Profiles
16.1.1. Abbott Laboratories
16.1.2. Acandis GmbH
16.1.3. Boston Scientific Corporation
16.1.4. Evasc Medical Systems Corp.
16.1.5. Johnson & Johnson Services, Inc.
16.1.6. LivaNova PLC
16.1.7. Medikit Co., Ltd.
16.1.8. Medtronic PLC
16.1.9. Microport Scientific Corporation
16.1.10. Penumbra, Inc.
16.1.11. Phenox GmbH
16.1.12. Rapid Medical Ltd.
16.1.13. Stryker Corporation
16.1.14. Terumo Corporation
16.2. Key Product Portfolio

17. Appendix

17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
FIGURE 7. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 10. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
FIGURE 12. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2030 (%)
FIGURE 14. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 18. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 28. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 18. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 26. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 31. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 62. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 63. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 64. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 69. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 94. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 95. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 96. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 100. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 101. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 102. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 112. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 113. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 114. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 143. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 148. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 149. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 150. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 154. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 155. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 156. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 167. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 168. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 169. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 171. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 173. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 174. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 175. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 179. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 180. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 181. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 186. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 187. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 192. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 197. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 198. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 201. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 203. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 204. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 205. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 219. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 221. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 222. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 223. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 225. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 227. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 228. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 229. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 231. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 233. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 234. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 235. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 255. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 257. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 258. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 259. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 273. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 275. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 276. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 277. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 291. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 292. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 293. NEUROVASCULAR INTERVENTION DEVICES MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Acandis GmbH
Boston Scientific Corporation
Evasc Medical Systems Corp.
Johnson & Johnson Services, Inc.
LivaNova PLC
Medikit Co., Ltd.
Medtronic PLC
Microport Scientific Corporation
Penumbra, Inc.
Phenox GmbH
Rapid Medical Ltd.
Stryker Corporation
Terumo Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.95 Billion
Forecasted Market Value ( USD ) by 2030	$ 5.83 Billion
Compound Annual Growth Rate	6.4%
Regions Covered	Global
No. of Companies Mentioned	14

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Neurovascular Intervention Devices Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Neurovascular Intervention Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Global Neurovascular Devices Market by Disease Pathology, Devices, End-User - Forecast 2024-2030

Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters), AVM (Liquid Embolic Agents), End User (Hospitals), & Region - Global Forecast to 2028

Neurovascular Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

About the Neurovascular Intervention Device Market